Overview

The Leukotriene Receptor Antagonist Montelukast in the Treatment of Non-alcoholic Steatohepatitis

Status:
Active, not recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The aim of the current study is to evaluate the safety and efficay of Montelukast in treatment of patients with fatty liver disease.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Sadat City University
Treatments:
Montelukast